Abbot Laboratories Whitepaper

Whitepaper: Considerations in Purchasing a LIMS

Randy C. Hice | Abbot Laboratories Many scientific enterprises find themselves in need of a Laboratory Information Management System (LIMS) to replace an incumbent system, whether an existing commercial application, an amalgam of systems, or an in-house solution. Once the decision has been made, the selection and deployment of a new LIMS should move quickly and decisively. This white paper …

Clinical Outsourcing

Recoding the Life Sciences Value Chain with Digital DNA

Take a look at the penetration of digital technologies within and across the life sciences value chain, and see how some organizations are digitally reimagining their businesses to drive growth, boost productivity. Life sciences companies need to generate higher revenues at reduced costs to sustain innovation. To achieve this optimal scenario, the industry is building new portfolios, expanding into new geographies, …

Clinical trials, Lionbridge Life Sciences, Life Science, Regulatory, Translations, Global communications

Efficient, Flawless Clinical Trial Translations

Successful global clinical trials require early consideration of the costs, complexities, and risks of communications. Best practices for clinical trials translation ensure your global trials are efficient, cost-effective, and successful in all markets. Language is a mission-critical element toward both culturally and regulatory-appropriate content contained in all forms of communication associated with clinical trials. Download our Clinical Trials Solution Brief to learn …

Attitudes on global clinical trials

Download eBook: Key factors surrounding the growth in global clinical trials

Clinicaltrials.gov indicates that more than half of clinical trials are being conducted outside the United States in developing countries, and that number is expected to grow. Why the dramatic change in acceptance of global clinical trials? Lionbridge Life Sciences had an opportunity to hear directly from many respected members of the Drug Information Association (DIA) at their 2014 Annual Meeting …